Los costos de la enfermedad laboral: revisión de literatura

Autores/as

  • Martha I. Riaño-Casallas Universidad Jorge Tadeo Lozano
  • Francisco Palencia-Sánchez Universidad Nacional de Colombia

DOI:

https://doi.org/10.17533/udea.rfnsp.v33n2a09

Palabras clave:

asignación de costos, costos y análisis de costos, costo de enfermedad, ausencia por enfermedad, salud laboral

Resumen


Objetivo: identificar el estado de desarrollo de la investigación sobre los costos de la enfermedad laboral que ha sido publicada en la literatura durante la última década en el mundo. Metodología: se realizó una búsqueda sistemática de literatura, altamente sensible, con el objetivo de identificar publicaciones que se adaptaran a los criterios de inclusión predefinidos por los autores. Se consultaron bases de datos como Pubmed, Ebsco, Lilacs, Online Wiley, Embase y Springer. El periodo de tiempo consultado fue 2000-2013. Resultados: Se incluyeron 54 artículos, de los cuales el mayor porcentaje están escritos en inglés, la mayoría fue producto de investigaciones realizadas en Estados Unidos. La metodología utilizada principalmente por los autores de los artículos fue del tipo de estudios de carga y costos de la enfermedad. Los costos incluidos en estas publicaciones fueron directos e indirectos en su mayoría y la perspectiva predominante fue la de tipo social. Conclusiones: Las economías más avanzadas del mundo son las que en su mayoría realizan este tipo de investigaciones, balance que resalta la importancia de realizar estos estudios para economías de países en desarrollo. Con respecto al lenguaje de publicación solamente se encontraron publicaciones en español realizadas en España, de ahí que sea necesario adelantar más estudios de este tipo en Latinoamérica.

|Resumen
= 218 veces | PDF
= 152 veces|

Descargas

Los datos de descargas todavía no están disponibles.

Biografía del autor/a

Martha I. Riaño-Casallas, Universidad Jorge Tadeo Lozano

Administradora de Empresas, Especialista en Salud Ocupacional, Magíster en salud y seguridad en el trabajo. Profesora de la Universidad Jorge Tadeo Lozano. Doctorado en Ciencias Económicas. Universidad Nacional de Colombia. Bogotá, Colombia.

Francisco Palencia-Sánchez, Universidad Nacional de Colombia

Médico, Especialista en salud ocupacional. Magíster en Epidemiología Clínica. Doctorado en Salud Pública. Universidad Nacional de Colombia, Bogotá, Colombia.

Citas

(1). CSDH. Closing the gap in a generation: health equity through action on the social determinants of health. Final Report. Geneva: World Health Organization; 2008.

(2). Commission of the European Communities. Improving quality and productivity at work: Community strategy 2007-2012 on health and safety at work. Communication. Brussels: The European Parliament; 2007.

(3). Mikheev M. New epidemics: the challenge for international health work. Helsinki: Finnish Institute of Occupational Health; 1994.

(4). Organización Internacional del Trabajo. sitio web OIT. [Internet]; 2003 [Acceso 25/12/2012]. Disponible en: http://www.ilo.org/global/about-the-ilo/newsroom/features/WCMS_075349/lang--es/index.htm.

(5). Maki K, Vathera J, Elovainio M. Sickness absence among female employees with migraine and coexisting conditions. Cephalalgia. 2008; 28 (11): 1136-1148.

(6). Fahs M, Markowitz S, Fischer E. Health costs of occupational disease in New York state. American Journal of Industrial Medicine. 1989; 16 (4): 437–449.

(7). Ministerio de la Protección Social - Colciencias. República de Colombia. Guía Metodológica para la elaboración de guías de atención integral en el Sistema General de Seguridad Social en Salud Colombiano. Primera ed. Torres JB, editor. Bogotá: Buenos & Creativos SAS.; 2010.

(8). Leigh J, Markowitz S, Fahs M. Occupational Injury and Illness in the United StatesEstimates of Costs, Morbidity, and Mortality. Arch Intern Med. 1997; 157 (14).

(9). Intenational Labour Organization. List of occupational diseases (revised 2010). Identification and recognition of occupational diseases: Criteria. Occupational Safety and Health Series, No. 74. Geneva: International Labour Office; 2010.

(10). Gardner HH, Kleinmanz NL. Workers’ compensation and family and medical leave act claim contagion. Journal of Risk and Uncertainty. 2000; 20: 89-112.

(11). Islam M, Anderson H. Status of work-related diseases in Wisconsin: five occupational health indicators. Wisconsin Medical Journal. 2006; 105 (2): 26-31.

(12). Leigh JP, Schanall P. Cost of occupational circulatory diseases. Occupational Medicine. 2000; 15 (1): 258-267.

(13). Access Economics. The economic and social costs of occupational disease and injury in New Zealand. Technical Report 4. Wellington: NOHSAC; 2006.

(14). Murphy PL, Courtney T. Low back pain disability: relative costs by antecedent and industry group. American Journal of Industrial Medicine. 2000; 37: 558-571.

(15). Watterson A, Gorman T, Malcolm C. The Economic Costs of Health Service Treatments for Asbestos Related Mesothelioma Deaths. Annals of the New York Academy of Sciences. 2006; 1076 (1): 871-881.

(16). Jonsson D, Husberg M, Götherström U. Cost-utility analysis of the rehabilitation of patients with musculoskeletal problems. International Advances in Economic Research. 2000; 6 (4): 741-48.

(17). García García AM, Gadea Merino R, López Martínez V. Estimación de la mortalidad atribuible a enfermedades laborales en España, 2004. Revista Española de Salud Pública. 2007; 81 (3): 261-70.

(18). Nathell L, Malmberg P, Lundback B. Impact of occupation respiratory disease. Scand J Work Environ Health. 2000; 26 (5): 382-389.

(19). Jensen S, McIntosh J. Absenteeism in the workplace: results from Danish sample survey data. Empirical Economics. 2007; 32 (1): 125-39.

(20). Weil D. Valuing the economic consequences of work injury and illness: a comparison of methods and findings. American Journal of Industrial Medicine. 2001; 40: p. 418 - 437.

(21). Hansson E, Hansson T. The cost–utility of lumbar disc herniation surgery. Eur Spine J.; 16 (3): 329-37.

(22). Leigh JP, Romano PS, Schenker MB. Costs of occupational COPD and asthma. CHEST. 2002; 121 (1): 264 - 272.

(23). Foley M, Silverstein B, Polissar N. The economic burden of carpal tunnel syndrome: long-term earnings of CTS claimants in Washington State. American journal of industrial medicine. 2007; 50 (3): 155-172.

(24). Guiffrida A, Fiunes R, Savedoff W. Occupational risk in Latin America and the Caribbean: economic and health dimensions. Health and policy planing. 2002; 17 (3): 235 - 246.

(25). Van den Heuvel SG, IJmker S, Blatter BM. Loss of Productivity Due to Neck/Shoulder Symptoms and Hand/Arm Symptoms: Results from the PROMO-Study. Occupational rehabil. 2007; 17 (3): 370-82.

(26). Horwitz IB, Kammeyer-Mueller J, McCall B. Workers’ compensation claims related to natural rubber latex gloves among Oregon healthcare employees from 1987–1998. BMC Public Health. 2002; 2:21.

(27). Burdof A. Economic evaluation in occupational health—its goals, challenges, and opportunities. Scand J Work Environ Health. 2007; 33 (3): 161-64.

(28). LushniakInt BD. The importance of occupational skin diseases in the United States. Arch Occup Environ Health. 2003; 76: 325:30.

(29). Wasiak R, Pransky G. The impact of procedure type, jurisdiction and other factors in workers’ compensation on work-disability outcomes following carpal tunnel surgery. Work: A Journal of Prevention, Assessment and Rehabilitation. 2007; 28 (2): 103-10.

(30). Liang YX, Wong O, Fu H. The economic burden of pneumoconiosis in China. Occup Environ Med. 2003; 60: 383: 84.

(31). Ares Camerino A, Sainz Vera B, Marchena Aparicio JC. Las enfermedades neoplásicas como causa de la incapacidad permanente. Medicina y seguridad del trabajo. 2008; 54 (210): 57-62.

(32). Diepgen TL. Occupational skin-disease data in Europe. Int Arch Occup Environ Health. 2003; 76: 331:38.33 Côté P, Van der Velde G, David Cassidy J. The burden and determinants of neck pain in workers. European Spine Journal. 2008; 17: 60-74.

(34). Leigh JP, Yasmeen S, Miller TR. Medical costs of fourteen occupational illnesses in the United States in 1999. Scand J Work Environ Health. 2003 29; 4: 304-13.

(35). McCulloch J. Counting the cost: Gold mining and occupational disease in contemporary South Africa. African Affairs. 2009; 108 (431): 221-240.

(36). Leigh J, Robbins J. Occupational disease and workers’ compensation: coverage, costs, and consequences. The Milbank Quarterly. 2004; 82 (4): 689–721.

(37). Alavinia M, Molenaar D, Burdorf A. Productivity loss in the workforce: associations with health, work demands, and individual characteristics. American journal of industrial medicine. 2009; 52 (1): 49-56.

(38). Rautiainen RH, Ohsfeldt R, Sprince NL, Donham KJ, Burmeister LF, Reynolds SJ, et al. Cost of compensated injuries and occupational diseasesin agriculture in Finland. Journal of Agromedicine. 2005; 10 (3): 22-29.

(39). Vermeulen S, Anema JR, Schellart AJ. Cost-effectiveness of a participatory return-to-work intervention for temporary agency workersand unemployed workers sick-listed due tomusculoskeletal disorders: design of a randomised controlled trial. BMC musculoskeletal disorders. 2010; 11 (1): 60.

(40). Abásolo L, Blanco M, Bachiller J. A Health system program to reduce work disability related to musculoskeletal disorders. Ann Intern Med. 2005; 143: 404-414.

(41). Uegaki K, de Bruijne MC, Lambeek L. Economic evaluations of occupational health interventions from a corporate perspective – a systematic review of methodological quality. Scand J Work Environ Health. 2010; 36 (4): 273-288.

(42). Béjean S, Sultan-Taïeb H. Modeling the economic burden of diseases imputable to stress at work. Eur J Health Econom. 2005; 50: 16-23.

(43). Evanoff B, Kymes S. Modeling the cost–benefit of nerve conduction studies in pre-employment screening for carpal tunnel syndrome. Scand J Work Environ Health. 2010; 36 (4): 299-304.

(44). Lahiri S, Markkanen P, Levenstein C. The cost effectiveness of occupational health interventions: preventing occupational back pain. American Journal of Industrial Medicine American Journal of Industrial Medicine. 2005; 48 (6): 515-529.

(45). Tufts JB, Weathersby PK, Rodriguez FA. Modeling the Unites States government’s economic cost of noise-induced hearing loss for a military population. Scand J Work Environ Health. 2010; 36 (3): 242-49.

(46). Lahiri S, Levenstein C, Nelson I. The cost effectiveness of occupational health interventions: prevention of silicosis. Sc.D. Journal of Industrial Medicine. 2005; 48 (6): 503-14.

(47). Van den Heuvel SG, Geuskens GA, Hooftman WE. Productivity loss at work; health-related and work-related factors. J Occup Rehabil. 2010; 20 (3): 331-339.

(48). Wild DM, Redlich CA, Paltiel AD. Surveillance for isocyanate asthma: a model based cost effectiveness analysis. Occup Environ Med. 2005; 62: 743-749.

(49). García M, Urbanos R, Castañeda R. Coste sanitario del asma, cáncer de vejiga, túnel carpiano y otra patología osteoarticular atribuible al trabajo en España en 2008. Informe de investigación. Madrid: Fundación Francisco Largo Caballero y Ministerio de Trabajo e Inmigración Madrid; 2010.

(50). Driscoll T, Nelson DI, Steenland K. The global burden of non-malignant respiratory disease due to occupational airborne exposures. American Journal of Industrial Medicine. 2005; 48: 432-445.

(51). Ayres JG, Boyd R, Cowie H. Costs of occupational asthma in the UK. Thorax. 2011; 66 (2): 128-33.

(52). McCall BP, Horwitz IB, Feldman SR, et al. Incidence rates, costs, severity, and work-related factors of occupational dermatitis. Arch Dermatol. 2005; 141: 713-18.

(53). Leigh JP. Economic burden of occupational injury and illness in the United States. Milbank Quarterly. 2011; 89 (4): 728-72.

(54). Schulte PA. Characterizing the burden of occupational injury and disease. Journal of Occupational and Environmental Medicine. 2005; 47 (6): 607-622.

(55). Meijster T, van Duuren-Stuurman B, Heederik D. Cost-benefit analysis in occupational health: a comparison of intervention scenarios for occupational asthma and rhinitis among bakery workers. Occup Environ Med. 2011; 68 (10): 739-745.

(56). Meerding WJ, Ijzelenber W, Koopmanschap MA. Health problems lead to considerable productivity loss at work among workers with high physical load jobs. Journal of Clinical Epidemiology. 2005; 58: 517-523

(57). García GM, Urbanos GR, Castañeda R. Costes sanitarios directos de las neoplasias de pulmón y vejiga de origen laboral en España en 2008. Revista Española de Salud Pública. 2012; 86 (2): 127-138.

(58). Fowler JF, Ghosh, Sung J. Impact of chronic hand dermatitis on quality of life, work productivity, activity impairment, and medical costs. J Am Acad Dermatol. 2006; 54: p. 448-57.

(59). Lee LJH, Chang YY, Liou SH. Estimation of benefit of prevention of occupational cancer for comparative risk assessment: methods and examples. Occup Environ Med. 2012; 69 (8): 582-586.

(60). Meijer EM, Sluiter JK, Heyma A. Cost-effectiveness of multidisciplinary treatment in sick-listed patients with upper extremity musculoskeletal disorders: a randomized, controlled trial with one-year follow-up. International archives of occupational and environmental health. 2006; 79 (8): 654-664.

(61). Lyons, Keegel T, Palmer A. Occupational dermatitis in hairdressers: do they claim workers’ compensation? Contact dermatitis. 2013; 68 (3): 163-168.

(62). Leigh JP, Waehrer G, Miller TR. Costs differences across demographic groups and types of occupational injuries and illnesses. American Journal of industrial medicine. 2006; 49 (10): 845-853.

(63). Jensen C, Nielsen CV, Jensen OK. Cost-effectiveness and cost-benefit analyses of a multidisciplinary intervention compared with a brief intervention to facilitate return to work in sick-listed patients with low back pain. Spine. 2013; 38 (13): 1057-1067.

(64). Leigh J, Macaskill P, Kuosma E. Global burden of disease and injury due to occupational factors. Epidemiology. 1999; 10 (5): 626-630.

(65). Abiuso D. Análisis de los costes de la siniestralidad laboral en Cataluña. Propuesta metodológica y cifras para los años 2006 y 2007. Informe metodológico. Cataluña: Universitat Pompeu Fabra, Departament d’Economia i Empresa; 2006.

(66). Pearce N, Dryson E, Feyer A. Access economics. The economic and social costs of occupational disease and injury in New Zealand. Technical Repor. Wellington: NOHSAC; 2006. Report No.: 0-478-28036-X.

(67). U.S Deparment of Labor. Lost work-time injuries and illnesses: charactheristic and resulting days away from work, 2001. News. Washington, D.C.: Bureau of Labor Statistics; 2001.

(68). Atroshi I, Gummesson C, Johnsson R. Prevalence of carpal tunnel syndrome in a generalpopulation. JAMA. 1999; 282 (2): 153-158.

(69). U.S. Deparment of Labor. Occupational injuiries and illnesses by selected characteristics. News. Washington: Bureau of Labor Statistics; 2007.

(70). Latinovic R, Gulliford M, Hughes R. Incidence of common compressive neuropathies in primary care. Journal of Neurology, Neurosurgery and Psychiatry. 2006; 77 (2): 263-265.

(71). Palmer D, Hanrahan L. Social and economic costs of carpal tunnel surgery. Instr Course Lect. Minneapolis: University of Minnesota, University of Minnesota; 1995. Report No.: 7797856.

Descargas

Publicado

2015-05-15

Cómo citar

1.
Riaño-Casallas MI, Palencia-Sánchez F. Los costos de la enfermedad laboral: revisión de literatura. Rev. Fac. Nac. Salud Pública [Internet]. 15 de mayo de 2015 [citado 3 de diciembre de 2021];33(2):218-27. Disponible en: https://revistas.udea.edu.co/index.php/fnsp/article/view/18930

Número

Sección

Revisión de tema